147 related articles for article (PubMed ID: 27249205)
1. A Pharmacokinetic Study Comparing Eslicarbazepine Acetate Administered Orally as a Crushed or Intact Tablet in Healthy Volunteers.
Sunkaraneni S; Kharidia J; Schutz R; Blum D; Cheng H
Clin Pharmacol Drug Dev; 2016 Jul; 5(4):278-84. PubMed ID: 27249205
[TBL] [Abstract][Full Text] [Related]
2. Dosage form proportionality and food effect of the final tablet formulation of eslicarbazepine acetate: randomized, open-label, crossover, single-centre study in healthy volunteers.
Fontes-Ribeiro C; Macedo T; Nunes T; Neta C; Vasconcelos T; Cerdeira R; Lima R; Rocha JF; Falcão A; Almeida L; Soares-da-Silva P
Drugs R D; 2008; 9(6):447-54. PubMed ID: 18989993
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects.
Nunes T; Sicard E; Almeida L; Falcão A; Rocha JF; Brunet JS; Lefebvre M; Soares-da-Silva P
Curr Med Res Opin; 2010 Jun; 26(6):1355-62. PubMed ID: 20377319
[TBL] [Abstract][Full Text] [Related]
4. Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations.
Fontes-Ribeiro C; Nunes T; Falcão A; Neta C; Lima R; Tavares S; Almeida L; Macedo T; Soares-da-Silva P
Drugs R D; 2005; 6(5):253-60. PubMed ID: 16128595
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects.
Almeida L; Nunes T; Sicard E; Rocha JF; Falcão A; Brunet JS; Lefebvre M; Soares-da-Silva P
Acta Neurol Scand; 2010 Apr; 121(4):257-64. PubMed ID: 20047572
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters.
Gidal BE; Mintzer S; Schwab M; Schutz R; Kharidia J; Blum D; Grinnell T; Sunkaraneni S
Epilepsy Res; 2017 Sep; 135():64-70. PubMed ID: 28624574
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence of eslicarbazepine acetate from two different sources of its active product ingredient in healthy subjects.
Falcão A; Lima R; Sousa R; Nunes T; Soares-da-Silva P
Drugs R D; 2013 Jun; 13(2):137-43. PubMed ID: 23677811
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
[TBL] [Abstract][Full Text] [Related]
9. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
10. Nasogastric administration of garenoxacin as crushed tablets with and without concomitant enteral feeding in healthy subjects.
Krishna G; Noveck R; Vargas R; Grasela D; Wang Z
Drugs R D; 2007; 8(1):43-50. PubMed ID: 17249848
[TBL] [Abstract][Full Text] [Related]
11. Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker.
Falcão A; Maia J; Almeida L; Mazur D; Gellert M; Soares-da-Silva P
Biopharm Drug Dispos; 2007 Jul; 28(5):249-56. PubMed ID: 17443646
[TBL] [Abstract][Full Text] [Related]
12. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Crushed Tablet for Oral Administration and the Effect of Food on Apixaban Pharmacokinetics in Healthy Adults.
Song Y; Chang M; Suzuki A; Frost RJ; Kelly A; LaCreta F; Frost C
Clin Ther; 2016 Jul; 38(7):1674-1685.e1. PubMed ID: 27292282
[TBL] [Abstract][Full Text] [Related]
14. Effect of food on the pharmacokinetic profile of eslicarbazepine acetate (BIA 2-093).
Maia J; Vaz-da-Silva M; Almeida L; Falcão A; Silveira P; Guimarães S; Graziela P; Soares-da-Silva P
Drugs R D; 2005; 6(4):201-6. PubMed ID: 15991880
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability and bioequivalence comparison of brivaracetam 10, 50, 75, and 100 mg tablets and 100 mg intravenous bolus.
Stockis A; Hartstra J; Mollet M; Hadi S
Epilepsia; 2016 Aug; 57(8):1288-93. PubMed ID: 27346728
[TBL] [Abstract][Full Text] [Related]
16. Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers.
Nunes T; Rocha JF; Falcão A; Almeida L; Soares-da-Silva P
Epilepsia; 2013 Jan; 54(1):108-16. PubMed ID: 22812691
[TBL] [Abstract][Full Text] [Related]
17. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
[TBL] [Abstract][Full Text] [Related]
18. An Open-Label Crossover Study of the Pharmacokinetics of the 60-mg Edoxaban Tablet Crushed and Administered Either by a Nasogastric Tube or in Apple Puree in Healthy Adults.
Duchin K; Duggal A; Atiee GJ; Kidokoro M; Takatani T; Shipitofsky NL; He L; Zhang G; Kakkar T
Clin Pharmacokinet; 2018 Feb; 57(2):221-228. PubMed ID: 28512699
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
Ahmad M; Pervaiz F
Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
[TBL] [Abstract][Full Text] [Related]
20. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
